{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T18:08:40Z","timestamp":1768500520684,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swiss Federal Institute of Technology Zurich"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Personal protective equipment (PPE) should effectively protect health care workers (HCWs) when treating infectious patients. However, during doffing contamination from outside of the PPE could be transferred and might cause serious infection. Therefore, complex doffing procedures have been developed, which include disinfection steps and would thereby protect the HCWs even if a contamination event occurred during doffing. However, assessing these complex multi-step procedures regarding risk of contamination and infection is challenging. The use of harmless surrogates with pathogen mimicking properties such as lipid nanoparticles encapsulating DNA (LNPs) could provide valuable insights into the effectiveness of doffing and disinfection procedures. Compared to the state-of-the-art method of contamination monitoring using fluorescent lotions LNPs promise to be more sensitive and give additional insights into the value of the disinfection steps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After pre-testing the suitability of LNPs as viral surrogates in terms of detection limit and susceptibility to ethanolic disinfection, LNPs with different barcodes were used to evaluate the PPE doffing procedure in place at the Cantonal Hospital Baden (Switzerland). During the biannual HCWs\u2019 PPE training, several sites of the PPE were deliberately contaminated with LNPs after donning. After completion of the doffing procedure, the hands and faces of the HCWs and several environmental sites were analysed for LNP contamination via qPCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis showed that no contamination of HCWs\u2019 hands and faces was detectable, indicating the effective protection of HCWs. But some environmental sites were contaminated during the doffing procedure. Owing to the disinfection sensitivity of the LNPs it could be shown that the LNPs detected were disintegrated during one of the disinfection steps of the procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that LNPs can be used as viral surrogates during the evaluation of PPE doffing procedures. LNPs can lead to insightful results due to their low detection limit and the susceptibility towards disinfection, making this method superior to fluorescent lotions. Consequently, indications for the procedures\u2019 effectivity in inhibiting pathogen transfer to HCWs were found using LNPs. At the same time, blind spots in environmental contamination were uncovered, and the necessity of the disinfection steps in the protocol was displayed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-025-01680-w","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:14:50Z","timestamp":1765437290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Doffing procedures of personal protective equipment evaluated with lipid nanoparticles as viral surrogates: uncovering potential blind spots"],"prefix":"10.1186","volume":"15","author":[{"given":"Lara","family":"Pfuderer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9e","family":"Friedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Wiggli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Grass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"5","key":"1680_CR1","first-page":"CD011621","volume":"5","author":"JH Verbeek","year":"2020","unstructured":"Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E, Blackwood B, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev. 2020;5(5):CD011621.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1680_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jinf.2018.08.016","volume":"77","author":"B Poller","year":"2018","unstructured":"Poller B, Tunbridge A, Hall S, Beadsworth M, Jacobs M, Peters E, et al. A unified personal protective equipment ensemble for clinical response to possible high consequence infectious diseases: a consensus document on behalf of the HCID programme. J Infect. 2018;77(6):496\u2013502.","journal-title":"J Infect"},{"key":"1680_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13756-018-0433-y","volume":"7","author":"LKP Suen","year":"2018","unstructured":"Suen LKP, Guo YP, Tong DWK, Leung PHM, Lung D, Ng MSP, et al. Self-contamination during doffing of personal protective equipment by healthcare workers to prevent Ebola transmission. Antimicrob Resist Infect Control. 2018;7:157.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"Suppl 3","key":"1680_CR4","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1093\/cid\/ciz614","volume":"69","author":"JM Mumma","year":"2019","unstructured":"Mumma JM, Durso FT, Casanova LM, Erukunuakpor K, Kraft CS, Ray SM, et al. Common behaviors and faults when doffing personal protective equipment for patients with serious communicable diseases. Clin Infect Dis. 2019;69(Suppl 3):S214\u201320.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1680_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/15459624.2023.2268727","volume":"21","author":"J Tu","year":"2024","unstructured":"Tu J, Liu F, Wang K, Mao Y, Qi Q, Zhang J. Donning and doffing of personal protective equipment for health care workers in a tertiary hospital in China: a simulation study. J Occup Environ Hyg. 2024;21(2):108\u201318.","journal-title":"J Occup Environ Hyg"},{"issue":"6","key":"1680_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/cid\/cix956","volume":"66","author":"LM Casanova","year":"2018","unstructured":"Casanova LM, Erukunuakpor K, Kraft CS, Mumma JM, Durso FT, Ferguson AN, et al. Assessing viral transfer during doffing of Ebola-level personal protective equipment in a biocontainment unit. Clin Infect Dis. 2018;66(6):945\u20139.","journal-title":"Clin Infect Dis"},{"key":"1680_CR7","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2024.84","author":"BA Berryhill","year":"2024","unstructured":"Berryhill BA, Burke KB, Smith AP, Morgan JS, Tarabay J, Mamora J, et al. A bacteriophage-based validation of a personal protective equipment doffing procedure to be used with high-consequence pathogens. Infect Control Hosp Epidemiol. 2024. https:\/\/doi.org\/10.1017\/ice.2024.84.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"1680_CR8","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1021\/acs.est.9b06034","volume":"54","author":"JP Wood","year":"2020","unstructured":"Wood JP, Richter W, Sunderman M, Calfee MW, Serre S, Mickelsen L. Evaluating the environmental persistence and inactivation of MS2 bacteriophage and the presumed Ebola virus surrogate Phi6 using low concentration hydrogen peroxide vapor. Environ Sci Technol. 2020;54(6):3581\u201390.","journal-title":"Environ Sci Technol"},{"key":"1680_CR9","doi-asserted-by":"crossref","unstructured":"Anderson B, Rashid Mh Fau - Carter C, Carter C Fau - Pasternack G, Pasternack G Fau - Rajanna C, Rajanna C Fau - Revazishvili T, Revazishvili T Fau - Dean T, et al. Enumeration of bacteriophage particles: Comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assays. Bacteriophage. 2011;1(2):86\u201393.","DOI":"10.4161\/bact.1.2.15456"},{"key":"1680_CR10","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.3c00004","author":"L Pfuderer","year":"2023","unstructured":"Pfuderer L, Stark WJ, Grass RN. Synthetic microbial surrogates consisting of lipid nanoparticles encapsulating DNA for the validation of surface disinfection procedures. ACS Appl Bio Mater. 2023. https:\/\/doi.org\/10.1021\/acsabm.3c00004.","journal-title":"ACS Appl Bio Mater"},{"key":"1680_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bdq.2017.04.001","volume":"12","author":"A Forootan","year":"2017","unstructured":"Forootan A, Sj\u00f6back R, Bj\u00f6rkman J, Sj\u00f6green B, Linz L, Kubista M. Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR). Biomol Detect Quantif. 2017;12:1\u20136.","journal-title":"Biomol Detect Quantif"},{"key":"1680_CR12","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1073\/pnas.1620874114","volume":"114","author":"JE Dahlman","year":"2017","unstructured":"Dahlman JE, Kauffman KJ, Xing Y, Shaw TE, Mir FF, Dlott CC, et al. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc Natl Acad Sci USA. 2017;114:2060\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1680_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00137-15","volume":"6","author":"MT Osterholm","year":"2015","unstructured":"Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, et al. Transmission of Ebola viruses: what we know and what we do not know. MBio. 2015;6(2):e00137.","journal-title":"MBio"},{"issue":"6","key":"1680_CR14","doi-asserted-by":"publisher","first-page":"409 e1-e4","DOI":"10.1016\/j.cmi.2016.12.030","volume":"23","author":"S Tschudin-Sutter","year":"2017","unstructured":"Tschudin-Sutter S, Rotter ML, Frei R, Nogarth D, Hausermann P, Stranden A, et al. Simplifying the WHO \u201chow to hand rub\u201d technique: three steps are as effective as six-results from an experimental randomized crossover trial. Clin Microbiol Infect. 2017;23(6):409 e1-e4.","journal-title":"Clin Microbiol Infect"},{"key":"1680_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhin.2020.09.026","volume":"107","author":"C Meyers","year":"2021","unstructured":"Meyers C, Kass R, Goldenberg D, Milici J, Alam S, Robison R. Ethanol and isopropanol inactivation of human coronavirus on hard surfaces. J Hosp Infect. 2021;107:45\u20139.","journal-title":"J Hosp Infect"},{"issue":"12","key":"1680_CR16","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.4315\/0362-028X-73.12.2232","volume":"73","author":"GW Park","year":"2012","unstructured":"Park GW, Barclay L, Macinga D, Charbonneau D, Pettigrew C, Vinj\u00e9 J. Comparative efficiency of seven hand sanitizers against Murine norovirus, feline calicivirus, and GII.4 norovirus. J Food Prot. 2012;73(12):2232\u20138.","journal-title":"J Food Prot"},{"issue":"5","key":"1680_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajic.2010.03.003","volume":"38","author":"EK Jeong","year":"2010","unstructured":"Jeong EK, Bae JE, Kim IS. Inactivation of influenza A virus H1N1 by disinfection process. Am J Infect Control. 2010;38(5):354\u201360.","journal-title":"Am J Infect Control"},{"key":"1680_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0195-6701(94)90140-6","volume":"28","author":"Jv Bueren","year":"1994","unstructured":"Bueren Jv, Larkin DP, Simpson RA. Inactivation of human immunodeficiency virus type 1 by alcohols. J Hosp Infect. 1994;28:137\u201348.","journal-title":"J Hosp Infect"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01680-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01680-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01680-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:35:41Z","timestamp":1768390541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13756-025-01680-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01680-w","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Board of the Northwestern and Central Switzerland (EKNZ) reviewed the study protocol and formally waved the necessity for a full ethics review based on the Swiss Law on Research on Humans [Req-2024-00797]. Study participants, adult healthcare workers and doctors, gave oral consent to participate, after being given information about the lipid nanoparticle surrogates. No personal information was collected or used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"L.P. and R.G. filed a patent application on the use of LNPs as pathogen surrogates, registered by ETH Zurich.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}